HOME >> MEDICINE >> NEWS
Genetic test for cell-proliferation enzyme could improve treatment of acute lymphoblastic leukaemia

Authors of a Canadian research letter in this weeks issue of THE LANCET describe how genetic testing for an enzyme involved in cancer-cell proliferation could identify patients at an increased risk of poor outcome from acute lymphoblastic leukaemia.

The enzyme thymidylate synthase is associated with cell proliferation, and is therefore an important target for anticancer drugs, including the chemotherapeutic agent methotrexate. Maja Krajinovic from the University of Montreal, Canada, and colleagues investigated the possible association between a variant of the gene coding for thymidylate synthase(in which a specific triple repeat alteration is associated with increased expression of thymidylate synthase) and the outcome of acute lymphoblastic leukaemia in 205 children treated with methotrexate.

DNA samples from patients were analysed for variation by polymerase chain reaction (PCR) amplification. Children who were homozygous for the triple repeat were four times more likely to have a poorer outcome than children with other genotypes.

Maja Krajinovic comments: Thymidylate synthase genotype seems to be a significant predictor of outcome in childhood acute lymphoblastic leukaemia. This finding could lead to individualisation of treatment for patients with this disease.


'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
21-Mar-2002


Page: 1

Related medicine news :

1. Genetics important in age-related macular degeneration
2. Genetic amplification (NAAT) test detects HIV more effectively than standard tests in urban study
3. Genetically targeted therapies create opportunities to do business in new ways
4. Genetic testing can identify ischemic and nonischemic heart failure
5. Genetics testing saves health care dollars
6. Genetic mutation linked to infant lung disease
7. Genetic switch proves two mechanisms exist by which immune system cells differentiate
8. Genetic risks for disease often missing from patient charts
9. Genetics of familial atrial fibrillation revealed, Science researchers report
10. Genetic variant may impact smoking cessation
11. Genetics in clinical practice: a revolutionary approach

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis ... are in a state of panic, experiencing deep anxiety, immense stress, and right now are ... is timely when most people on the planet are experiencing a great degree of emotional ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... intended to improve outcomes for patients with advanced heart failure, today announced that ... grant in the amount of $555,358 from the National Heart, Lung, and Blood ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , ... treat patients with respiratory conditions, including COVID-19, while reducing the need for scarce ... it captures exhaled gas and scrubs it free of carbon dioxide in a ...
(Date:8/28/2020)... ... 28, 2020 , ... Integrated Viral Protection (IVP Air) today announced ... deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is the first system ... to fully reopen equipped with the filtration system on September 8th. , The ...
(Date:8/27/2020)... ... August 27, 2020 , ... Walk-in Dermatology’s SK-IN Medical Aesthetics ... Greenvale, New York location. , Loren received her New York esthetic license ... in chemical peels, microdermabrasion, Hydrafacial MD, dermaplaning, facial lymphatic, and various laser procedures. ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J ... ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests on Q&J’s personal ... the COVID-19 virus than many other masks. Q&J face masks have both mechanical ...
(Date:9/2/2020)... Md. (PRWEB) , ... September 02, 2020 , ... ... Dr. Jonathan Lee . Dr. Lee will work at Bethesda Dermatopathology Lab. ... with his B.A. from the University of California, Berkley. He went on to receive ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are common diseases ... 3% of breast cancers (about 7,500 women per year) and 10% of ovarian cancers ... genes. Both genes are detectable in the Women’s Excellence Genetic Testing Program. , ...
Breaking Medicine Technology:
Cached News: